|Immunogen||VZV Ellen Strain from VZV-infected monkey kidney cells (BSC-1).|
|Purification||Protein G Chromatography|
|Target/Specificity||Reacts with VZV glycoprotein IV (VZVgI) and to a lesser extent VZV glycoprotein I (VZVgE) by immunoprecipitation test. This clone reacts with both precursor and mature glycoprotein IV (VZVgI).|
|Storage||Short term (up to 7 days) store at 2-8°C. Long term, aliquot and store at -20°C. Avoid multiple freeze/thaw cycles.|
|Precautions||Monoclonal Antibody to Varicella-Zoster Virus (VZVgpIV) [SG4] is for research use only and not for use in diagnostic or therapeutic procedures.|
email@example.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
The references listed below are for research purposes only:1. Sato, H., et al., (2003), “Varicella-Zoster Virus ORF47 Protein Kinase, which is required for Replication in Human T cells, and ORF66 Protein Kinase which is expressed during Latency, are dispensable for establishment of Latency”, Journal of Virology, 77(20): 11180-11185.2. Weller, T.H., (1979), “Varicella and Herpes Zoster. In:Diagnostic Procedures for Viral, Rickettsial and Chlamydial Infections”, (Lennette, E.H. and Schmidt, N.J., eds.) American Public Health Associations, Inc. Washington D.C., pp 375-398.3. Drew, W.L., et al., (1980), “Rapid diagnosis of varicella-zoster virus infection by direct immunofluorescence”, Am. J. Clin. Pathol., 73: 699-701.4. Davison et al, (1986), “New common nomenclature for glycoprotein gene of varicella-zoster virus and their glycosylated products”, J. Virol., 57: 1195-1197.
If you have any additional inquiries please email technical services at firstname.lastname@example.org.